Pneumonectomy is not a risk factor in trimodality therapy for stage III NSCLC

被引：0
|
作者：
Steger, Volker [1 ]
Walles, Thorsten [1 ]
Kosan, Bora [1 ]
Veit, Stefanie [1 ]
Walker, Tobias [2 ]
Kyriss, Thomas [1 ]
Friedel, Godehard [1 ]
机构：
[1] Schillerhoehe Hosp, Dept Thorac Surg, Gerlingen, Germany
[2] Univ Tubingen, Dept Cardiac Thorac & Vasc Surg, Tubingen, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S520 / S521
页数：2
相关论文
共 50 条
  • [1] BIMODALITY AND TRIMODALITY THERAPY IN STAGE III NSCLC: ANALYSIS OF TOXICITY AND PATTERNS OF RECURRENCE
    Van Reij, Ellen J. F.
    Phernambucq, Erik C.
    De Haan, Patricia F.
    Oei, Swie S.
    Smit, Egbert F.
    Paul, M. A.
    Senan, Suresh
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1590 - S1590
  • [2] Outcomes of Bimodality and Trimodality Therapy in Patients with Stage III Non-small Cell Lung Cancer (NSCLC)
    Hope, A. J.
    Coate, L. E.
    Massey, C.
    Sacher, A.
    Barrett, K.
    Keshavjee, S.
    Darling, G.
    Leighl, N. B.
    Bezjak, A.
    Shepherd, F. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S505 - S505
  • [3] Evaluate the outcome of pneumonectomy for stage III a-N2 NSCLC
    Sungjoon Park
    Hyo-Jun Jang
    Eunjue Yi
    Sukki Cho
    Sanghoon Jheon
    Kwhanmien Kim
    [J]. Journal of Cardiothoracic Surgery, 10 (Suppl 1)
  • [4] COUNTERPOINT: Pneumonectomy after chemoradiation: The risks of trimodality therapy
    Krasna, Mark J.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (02): : 295 - 299
  • [5] Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of Immunotherapy
    Moore, Sara
    Leung, Bonnie
    Wu, Jonn
    Ho, Cheryl
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) : 1430 - 1439
  • [6] Trimodality therapy for stage IIINSCLC
    Krasna, Mark J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S150 - S152
  • [7] Safety and efficacy of trimodality therapy in patients undergoing extrapleural pneumonectomy
    Boeluekbas, Servet
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (02) : 130 - 131
  • [8] Safety and efficacy of trimodality therapy in patients undergoing extrapleural pneumonectomy
    Servet Blükbas
    [J]. Chinese Journal of Cancer Research, 2013, 25 (02) : 130 - 131
  • [9] Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?†
    Steger, Volker
    Spengler, Werner
    Hetzel, Juergen
    Veit, Stefanie
    Walker, Tobias
    Mustafi, Migdat
    Friedel, Godehard
    Walles, Thorsten
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 41 (04) : 880 - 885
  • [10] Patient and Institutional Predictors of Trimodality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC) in the National Cancer Database
    Sher, D. J.
    Liptay, M. J.
    Fidler, M. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S180 - S180
12345